IDH1 and glioblastoma: In this study, they proposed a metagene score of the mesenchymal signature, which consists of proteins such as YKL40, SERPINE1, TIMP1 and TGFBI, and showed that GBM patients with higher mesenchymal metagene score are associated with poor response to radiation regardless of IDH1/2 mutational status [11].